Libri di Deepak L. Bhatt

Authoritative, portable, and up to date, Opie's Cardiovascular Drugs, 9th Edition, is the definitive reference for quick access to frequently used drugs in all phases of care for cardiac patients. Now a part of the Braunwald family of renowned cardiology references, this compact title provides crucial information in an easily accessible format-ideal for cardiologists, residents, cardiology fellows, medical students, nurses, and other cardiac care providers. Updated to include the latest guidelines and evidence-based implications, it offers clear and concise explanations and pertinent clinical facts for all classes of cardiac drugs, as well as all the latest clinical trial results and evidence for the pharmacologic treatment of heart disease. Uses a new, consistent format for each drug class: overview and guidelines for use, mechanisms of action, differences among drugs in class, data for use, side effects, and drug interactions. Covers key topics such as new ESC and NLA guidelines, advances in lipid-lowering therapy, new diabetes drugs that improve cardiovascular outcomes, obesity drugs and cardiovascular and metabolic effects, drugs targeting inflammation, and combinations of antithrombotic therapies with analysis of risk-benefit. Provides guidance on how to effectively manage comorbid diseases. Contains dozens of unique "Opiegram" diagrams that demystify complex mechanisms of action and other drug processes-many updated to reflect current pathologic understanding of mechanisms. Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices

Introducing Cardiovascular Intervention, a comprehensive companion volume to Braunwald's Heart Disease. This medical reference book contains focused chapters on how to utilize cutting-edge interventional technologies, with an emphasis on the latest protocols and standards of care. Cardiovascular Intervention also includes an eBook updated with late-breaking clinical trials, "Hot off the Press" commentary, and Focused Reviews that are relevant to interventional cardiology.

The World Health Organization has projected that the prevalence of diabetes will double over the next 22 years - from a current figure of 150 million to an estimated 300 million people by the year 2025. The health-care burden of diabetes is enormous, and effective strategies to combat the explosive rise in the global incidence and prevalence of diabetes are urgently needed. Furthermore, diabetic patients have a considerable risk for cardiovascular disease, with up to 80% of deaths in individuals with diabetes attributable to microvascular or macrovascular complications. This book provides a concise overview of the present state-of-the-art relating to the impact of diabetes mellitus on cardiovascular disease and to emerging treatment strategies that are beginning to impact on the management of the cardiovascular complications of this debilitating condition.